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Abstract
Background: The interfacial molecular mechanisms that regulate mammalian cell growth and differentiation have 
important implications for biotechnology (production of cells and cell products) and medicine (tissue engineering, 
prosthetic implants, cancer and developmental biology). We demonstrate here that engineered protein motifs can be 
robustly displayed to mammalian cells in vitro in a highly controlled manner using a soluble protein scaffold designed 
to self assemble on a gold surface.
Results: A protein was engineered to contain a C-terminal cysteine that would allow chemisorption to gold, followed 
by 12 amino acids that form a water soluble coil that could switch to a hydrophobic helix in the presence of alkane 
thiols. Bioactive motifs from either bone morphogenetic protein-2 or osteopontin were added to this scaffold protein 
and when assembled on a gold surface assessed for their ability to influence cell function. Data demonstrate that 
osteoblast adhesion and short-term responsiveness to bone morphogenetic protein-2 is dependent on the surface 
density of a cell adhesive motif derived from osteopontin. Furthermore an immobilised cell interaction motif from 
bone morphogenetic protein supported bone formation in vitro over 28 days (in the complete absence of other 
osteogenic supplements). In addition, two-dimensional patterning of this ligand using a soft lithography approach 
resulted in the spatial control of osteogenesis.
Conclusion: These data describe an approach that allows the influence of immobilised protein ligands on cell 
behaviour to be dissected at the molecular level. This approach presents a durable surface that allows both short 
(hours or days) and long term (weeks) effects on cell activity to be assessed. This widely applicable approach can 
provide mechanistic insight into the contribution of immobilised ligands in the control of cell activity.
Background
I t  h a s  l o n g  b e e n  r e c o g n i s e d  t h a t  c e l l  r e g u l a t o ry  m o l e -
cules, such as growth factors and cytokines, exert power-
ful influences on the behaviour of eukaryotic cells at the
interface of tissues. Indeed the immobilized activity of
these signalling mediators in combination with the extra-
cellular matrix (ECM) underpins many fundamental bio-
logical processes including embryo-, morpho- and
tumorogenesis and wound healing [1]. Numerous studies
have established the principle that tethered ligands regu-
late cell behavior quite distinctly from their freely diffus-
ible counterpart. For example, extracellular matrix
proteins like fibronectin promote adhesion [2] and
migration [3] on a surface but when added exogenously to
cells can have adhesion-independent effects, for example
activating intracellular signalling cascades [4]. Further-
more, soluble growth factors, like fibroblast growth factor
(FGF)-2, vascular endothelial growth factor (VEGF) and
interleukin (IL)-1 exhibit elevated activity when pre-
sented within the context of matrix such as fibrin [5-7].
Whilst these and many other studies have provided fun-
damental insight into the underlying biology, the experi-
mental approaches have meant that immobilised ligands
are often presented in orientations and conformations
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that are not well controlled, at densities that are poorly
characterised and under conditions in which the durabil-
ity and stability of the ligand is undefined.
Our approach has been to design and fabricate protein
scaffolds that can display protein ligands on self-assem-
bled monolayers (SAM) in a controlled and reproducible
way [8,9]. This work uses a TolAIII-fusion expression sys-
tem to provide the engineered protein at high yields and
solubility [10]. A cysteine residue engineered into the C-
terminal end of the protein ensures durable chemisorp-
tion onto gold surfaces whilst a 12 amino acid stretch
termed the switch-tag (ST) can switch from a water solu-
ble coil to a hydrophobic helix that co-assembles with the
alkane thiols of the SAM [8]. Therefore formation of a
SAM containing both the scaffold protein and an
amphiphile produces a surface where the orientation of
the protein is controlled and non-specific interactions are
low. These surfaces provide the opportunity to address
how immobilised ligands can both provide insights into
cell function and contribute to tissue engineering.
We demonstrate here the ability of this system to influ-
ence the long term function of cells in vitro via the incor-
poration of two distinct ligand motifs. The first is derived
from the extracellular matrix protein, osteopontin
(OPN), and was identified as supporting cell adhesion
through the α9β1 integrin [11] and subsequently shown to
promote adhesion and migration of endothelial cells lead-
ing to enhanced angiogenesis [12-14]. The second is the
knuckle epitope from bone morphogenetic protein
(BMP)-2, a member of the transforming growth factor
(TGF)β superfamily, which has been widely shown to
support commitment of cells to the osteoblastic lineage,
their differentiation and functional ability to make bone
[15,16].
Here we show that Tol-OPN-ST dose-dependently sup-
ported the adhesion and spreading through vinculin
adhesion sites of primary rat osteoblasts. Biological activ-
ity of the BMP motif within the scaffold protein was veri-
fied by adding the recombinant protein to cells
transfected with a Sma- and MAD-related protein
(SMAD) responsive-reporter construct and demonstrat-
ing SMAD1 activation. Tol-BMP2-ST reproduced BMP
signalling and produced bone-like nodules on patterned
surfaces.
This technology effectively immobilises bioactive pro-
tein motifs on a surface for analysis of cell behaviour in
vitro and may provide the basis for future tissue engineer-
ing approaches.
Results
Incorporating osteopontin or BMP2 motifs in the Tol 
scaffold protein does not influence its binding to gold
The motifs from osteopontin and BMP2 were inserted
between Tol and the Switch tag to create Tol-OP-ST and
Tol-BMP-ST respectively (Figure 1). This design ensured
that the C-terminal cysteine was available to bind gold
surfaces and that the biological activity of the inserted
motifs is not compromised. BIAcore analysis (Table 1)
shows that Tol-OP-ST and Tol-BMP-ST specifically inter-
act with the gold surface and, interestingly, binding of
Tol-OPN-ST and Tol-BMP-ST was slightly higher than
Tol-ST alone. The vector includes a protease cleavage site
which can remove the Tol protein leaving just OPN-ST or
BMP-ST. However since the larger construct is more sta-
ble and easier to handle in solution, the initial studies
used the complete fusion protein
Cells specifically interact with immobilised Tol-OPN-ST
Having demonstrated that the proteins chemisorb to the
gold surface irrespective of the active motif inserted in
Figure 1 The design of the Tol switch tag system, a molecular im-
age (left) and a schematic (right). The protein starts at the N-termi-
nus with a 6 His tag for easy purification followed by a FLAG-tag 
sequence to aid detection. The TolAIII domain which comes next pro-
vides solubility and drives high levels of expression for fusion proteins 
attached to its C terminus [10]. The fusion sequence is inserted be-
tween the TolA and the switch tag, which is found at the C terminus, 
by use of a multiple cloning site in the plasmid [8]. The TolA domain 
can be removed by specific proteolytic cleavage but in most cases it is 
left in place since it stabilises the fusion construct. The switch tag is 
shown here as a helix whose hydrophobic properties allow co assem-
bly with alkane thiol SAM, in solution it is a water soluble random coil.Mitchell et al. BMC Biology 2010, 8:57
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the scaffold, the ability of the cells to interact with these
immobilised proteins under serum-free conditions was
determined (Figure 2a, b, c, d). After 24 hours of culture
Tol-OPN-ST promoted the attachment of significant (P <
0.01) numbers of cells compared to all other surfaces (Fig-
ure 2e). Analysis of cell morphology revealed that on Tol-
OPN-ST, area (Figure 2f) was significantly (P  < 0.05)
enhanced compared to bare gold/11-mercapto-1-triethyl-
eneglycolundecane (TEG-thiol) whilst circularity (Figure
2g) was significantly (P < 0.01) different from all of the
other surfaces that were studied. In addition, around the
periphery of the cells there were focal contacts, charac-
terised by the identification of the protein vinculin by
immunofluorescence. These contacts are important since
this is where the cell interacts with the extracellular
matrix (Figure 2a) with significantly (P < 0.01) increased
abundance of vinculin in cells on Tol-OPN-ST compared
to all of the other surfaces (Figure 2h). Cells on the Tol-
OPN-ST surface also exhibited a more spread out mor-
phology that correlates with a more robust cytoskeleton
consisting of numerous actin filaments (Figure 2f, g). Rel-
atively few cells were observed to adhere to the surfaces
displaying immobilised Tol-BMP2-ST (Figure 2c, e) or
Tol-green fluorescent protein (GFP) (Figure 2b, e), indeed
these surfaces were little different to surfaces composed
solely of the anti-adherent TEG-thiol (Figure 2d, e). Fur-
thermore those cells that grew on Tol-BMP, Tol-GFP and
control TEG alone formed fewer focal contact structures
and were less well spread on the surfaces (Figure 2f, g, h).
Next we investigated cell adhesion on surfaces with
varying densities of immobilised scaffold (Figure 3a, b, c).
Scaffold was immobilised at different densities by adjust-
ing the coating concentration of protein. The number of
cells binding to the osteopontin surface was dependent
on the surface density of Tol-OP-ST (Figure 3d) and this
correlated closely with both cell area (Figure 3e) and the
abundance of vinculin-containing focal contact struc-
tures (F igure 3f). Analysis of cell morphology on these
surfaces demonstrates the influence of Tol-OPN-ST den-
sity on cell behaviour. At relatively low density (2.1 × 107
molecules/mm2) Tol-OPN-ST surfaces promote poor cell
adhesion and limited cell spreading. While at a high den-
sity (1.6 and 3.3 × 1010 molecules/mm2), Tol-OPN-ST
supports significant cell adhesion (P < 0.01), extensive cell
spreading (P < 0.05) and the formation of significantly
more abundant and complex cytoskeletal elements (P <
0.01). At an intermediate surface density (2.7 × 109 mole-
cules/mm2) (Figure 3b), cell adhesion is more weakly pro-
moted with cellular processes extended but not
sufficiently strengthened to facilitate cell spreading. To
further illustrate the biological specificity of our
approach we investigated the cellular response to soluble
recombinant BMP2 (srBMP2) when cultured on surfaces
displaying different densities of Tol-OPN-ST. It is widely
appreciated that integrin-mediated adhesion influences
the regulation of growth factor induced signalling cas-
cades and indeed this phenomenon is believed to under-
pin numerous biological events such as morphogenesis
and wound healing [17]. For this study, osteoblasts were
transfected with a luciferase reporter construct driven by
SMAD-binding elements and cultured on different densi-
ties of immobilised Tol-OP-ST for eight hours under
serum-free conditions. The cells were then treated with
soluble recombinant BMP2 and the response assessed
through analysis of luciferase activity (Figure 3e). Cells
that were more extensively spread on higher densities of
Tol-OP-ST exhibited significantly (P < 0.01) higher levels
of BMP-induced signalling compared to cells that were
poorly spread and showing fewer adhesion complexes on
low density Tol-OP-ST. This confirms that BMP receptor
activation is influenced by the density of ECM ligands.
Osteoblasts respond specifically to both soluble and 
immobilised Tol-BMP-ST
To test the ability of Tol-BMP-ST to activate BMP-depen-
dent intracellular signalling, it was added exogenously to
cells growing on conventional tissue culture plasticware.
Analysis reveals that cells transfected with SMAD-bind-
ing promoter construct were dose-dependently respon-
sive to both soluble recombinant BMP2 and Tol-BMP-ST
(Figure 4a) with the highest doses significantly different
from Tol-ST alone (P  < 0.01). The cells exhibited no
Table 1: SPR data of the Tol, Tol-Osteopontin (Tol-OP) and Tol-BMP proteins binding to a gold surface in SPR analysis 
(BIAcore).
Protein rU increase Mr of protein moles/mm2 Molecules/mm2
Tol 1,526.53 1,4874.4 1.03 × 10-13 6.4 × 1010
Tol-Op 4,381.15 18,407.3 2.38 × 10-13 14.8 × 1010
Tol-BMP 3,162.26 17,894.8 1.77 × 10-13 11.0 × 1010
The proteins were added at a concentration of 5 mM in a total volume of 30 μl over a period of 15 minutes.Mitchell et al. BMC Biology 2010, 8:57
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Figure 2 Immobilised Tol scaffold containing the osteopontin motif, SVVYGLR, specifically controls cell adhesion and cell morphology. 
Cells were plated onto surfaces displaying scaffold proteins in the absence of serum supplements and assessed after 24 hours. Immunolocalization of 
vinculin and counterstaining with DAPI allowed identification of focal adhesion complexes (white arrow) in cells on (a) Tol-OPN-ST; (b) Tol-GFP-ST; (c) 
Tol-BMP-ST; (d) TEG. Size bars = 200 μm and 50 μm in the inset images. Image analysis demonstrated significant differences in (e) the number of cells 
adhered to Tol-OPN-ST compared to all other surfaces; (f) the area of cells on Tol-OPN-ST compared to TEG; (g) the circularity of cells on Tol-OPN-ST 
compared to the other surfaces and (h) abundance of vinculin positivity in cells on Tol-OPN-ST compared to other surfaces. Data representative of 
three independent experiments; results are mean ± SEM; *P < 0.05, ** P < 0.01. Significance was determined by ANOVA with Fisher post test.Mitchell et al. BMC Biology 2010, 8:57
http://www.biomedcentral.com/1741-7007/8/57
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Figure 3 Tol-OP-ST surface density influences cell morphology and response to BMP2. Gold coverslips were incubated with different concen-
trations of Tol-OP-ST and based on SPR analysis surface densities calculated (molecules/mm2). (a, b, c) Cells were plated onto the surfaces, as indicat-
ed, under serum free conditions and vinculin immunolocalized 24 hours later. Size bars = 50 μm. (d) DAPI was used to visualize nuclear DNA and 
images quantified to show number of adhered cells. Numbers of cells on 1.6 and 3.3 × 1010 molecules/mm2 were significantly different to all other 
surfaces. (e) Assessment of cell area revealed that cells on 1.6 and 3.3 × 1010 molecules/mm2 were significantly different to all other surfaces. Further-
more (f) levels of vinculin positivity were significantly higher in cells on 1.6 and 3.3 × 1010 molecules/mm2 in comparison to lower densities. (g) Cells 
transfected with a SMAD-reporter construct were plated on the surfaces, treated with 100 ng/ml recombinant BMP-2 and levels of luciferase assessed 
and normalised to cell number. Data representative of three independent experiments; results are mean ± SEM; * P < 0.05, ** P < 0.01. Significance 
was determined by ANOVA with Fisher post test.
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response above background to the Tol protein vector
alone. Next, cells transfected with the same reporter con-
struct were plated onto specific Tol-X-ST surfaces (Figure
4b). Only those cells grown on the Tol-BMP-ST surface
demonstrated activation of the SMAD signalling pathway
that was comparable to the effect of soluble recombinant
BMP . Levels of SMAD signalling observed on both T ol-
BMP-ST surfaces and in those cells treated with recombi-
nant BMP2 were significantly different (P < 0.01) com-
pared to all other surfaces.
Immobilised Tol-BMP-ST induces enhanced osteogenesis in 
vitro
Tol-BMP-ST, Tol-OPN-ST and Tol-ST were then com-
pared for their ability to influence the long term behav-
iour of cells in vitro. Primary rat osteoblasts can be
cultured in media supplemented with β-glycerophos-
phate, L-ascorbic acid and dexamethasone to promote
osteogenic differentiation over a period of weeks [18,19].
In the absence of this chemical cocktail the cells retain a
more primitive fibroblastic phenotype. In our experi-
ments, cells were maintained in culture without these sol-
uble supplements so that the only potential osteogenic
signal was from the engineered surfaces. In this environ-
m e n t  c e l l s  p r o l i f e r a t e d  a n d  a c h i ev e d  c o n fl u e n c e  o n  a l l
surfaces after three days. After two weeks of culture there
was clear evidence of cells on Tol-BMP-ST surfaces
beginning to form multilayers and discrete cellular aggre-
gates. This behaviour was not repeated on Tol-OPN-ST,
Tol-ST or other control surfaces. After four weeks, in the
absence of further osteogenic factors, extensive bone-like
nodule formation was observed on Tol-BMP-ST (Figure
5b, d) which was significantly (P < 0.01) more extensive
than on the other surfaces investigated. There was some
evidence of mineralised matrix production on Tol-OP-ST
(Figure 5c) whilst on Tol-ST alone (Figure 5a) and bare
gold there very few bone-like nodules (Figure 5d).
Surface patterns of Tol-BMP-ST induce spatially restricted 
osteoblast differentiation
Whilst osteoblasts displayed enhanced differentiation
when cultured on surfaces displaying Tol-BMP-ST it was
not clear if Tol-BMP-ST was acting after desorption from
the surface. To address this, patterned surfaces were cre-
ated using a microcontact printing approach [8]. A poly-
dimethylsiloxane (PDMS) stamp displaying microscale
features was inked with Tol-BMP-ST and used to transfer
a protein pattern to the gold surface. The gaps between
the protein and between patterns were backfilled by incu-
bation of the whole surface with TEG-thiol. Osteoblasts
were cultured on these surfaces for two weeks and differ-
entiation assessed by staining for alkaline phosphatase
activity (Figure 6b). During two weeks cells grew all over
the surface both in regions that were stamped with the
Tol-BMP-ST pattern and those that were not (Figure 6a).
The marker of osteoblast differentiation, alkaline phos-
phatase was principally localised to the regions where
Tol-BMP was immobilised (Figure 6b). These experi-
ments demonstrated that bioactive signalling was
restricted to the patterned areas suggesting that surface
Figure 4 Tol scaffold containing the BMP2 knuckle peptide, KIP-
KASSVPTELSAISTLYL, activates Smad dependent signalling both 
when added exogenously to adherent cells and when immobil-
ised on a surface. (a) Cells were cultured in multiwell plates, transfect-
ed with a SMAD-reporter construct and then treated with 
recombinant BMP2, exogenous Tol-BMP-ST or Tol-ST. Levels of lu-
ciferase were then assessed after eight hours. Both recombinant BMP2 
(31 nM) and Tol-BMP-ST (112 nM) induced significant levels of lu-
ciferase activity compared to Tol alone. (b) Cells already transfected 
with the SMAD-reporter construct were plated onto gold coverslips 
displaying the scaffold proteins at the concentrations outlined in Table 
1 or TEG alone. Luciferase activity was measured 12 hours later and 
contrasted with the same cells grown on tissue culture plastic and 
treated with soluble recombinant BMP-2 (100 ng/ml). Significant levels 
of SMAD signalling were only observed on the Tol-BMP-ST surface. 
Data representative of three independent experiments; results are 
mean ± SEM; ** P < 0.01. Significance was determined by ANOVA with 
Tukey post test.
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tethered ligand was predominantly responsible for the
regulation of cell activity and not Tol-BMP-ST released
from the surface.
Discussion
Signalling by interfacial motifs is a fundamental biologi-
cal mechanism that underpins numerous aspects of mor-
phogenesis and wound healing [1]. Tools that enable
further insight into how immobilized ligands regulate cell
behaviour will not only provide mechanistic understand-
ing but also the basis for therapeutic approaches such as
tissue engineering [20]. Our results show that a generic
immobilisation system with a variable motif sandwiched
between expression enhancing and self assembly domains
(Tol-motif-ST) can present the motifs in a functional
state at the surface of a SAM. The fusion protein is easily
produced in large amounts in E coli and is easy to convert
from a highly water soluble state to a SAM inserted form
on gold [8]. Analysis by SPR of the Tol-ST proteins on a
gold surface interestingly provided evidence that Tol-
OPN-ST and Tol-BMP-ST pack at higher surface densi-
ties than Tol-ST alone. This may arise from flexibility
introduced into the protein by the inclusion of the short
OP and BMP motifs. The highest flexibility is expected
from the OP domain as there are three linker sequences
found in this sequence whilst the BMP motif is shorter. In
addition analysis of Tol-GFP (data not shown) assembly
by SPR shows this rigid construct to be similar to Tol
alone, supporting the possibility that protein flexibility
plays a role in its packing on the surface. Thus retention
of the N terminal Tol domain does not inhibit self assem-
bly and likely serves to solubilise and protect the flexible
peptides from degradation, presenting the biologically
active motifs in a more constrained structure.
Figure 5 Long term growth of calvarial-derived cells on scaffold proteins. After four weeks under routine culture conditions and in the absence 
of exogeneous osteogenic factors mineralized matrix was visualized with Alizarin red staining. There was little evidence of mineralised matrix on (a) 
Tol alone, whilst abundant deposition was observed on (b) Tol-BMP-ST and a small amount on (c) Tol-OP-ST surfaces. Size bar = 400 μm. (d) Image 
analysis shows significant evidence of mineralised matrix deposition only on Tol-BMP surfaces. Data representative of three independent experiments; 
results are mean ± SEM; ** P < 0.01. Significance was determined by ANOVA with Tukey post test.
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The biological activity of the Tol-ST surfaces was first
determined in simple cell adhesion assays performed in
the absence of serum. The abundant cell adhesion on Tol-
OPN-ST, in contrast to the other surfaces, is most likely
mediated by α9β1 integrin as described for endothelial
cells [11-14]. Calvarial derived osteoblasts have not been
previously shown to express α9β1 integrins but they can
be found on periodontal ligament cells [21] and cells of
the osteoclast lineage [22]. The adhesion and spreading of
cells described here is a possible demonstration of α9β1
integrins activity in these cells but an alternative mecha-
nism cannot be discounted.
Surface assembly techniques provide the ability to con-
trol surface density of cell interaction motifs. Reducing
the apparent density of Tol-OP-ST had significant effects
on cell shape, morphology and numbers of vinculin-posi-
tive focal contacts. This revealed a threshold level of Tol-
OP-ST below which cytoskeletal tensioning and remodel-
ling cannot be supported (2.7 × 109 molecules/mm2), and
above which the cells can interact with the surface initiat-
ing morphological change and regulation of cell behav-
iour. The estimated density measured here compares
with other approaches that have attempted to address
this issue where cells of fibroblastic origin exhibited
increased cell adhesion and spreading on integrin ligands
of the order 109 molecules/mm2 [23-25]
The way in which cells adhere and interact with the sur-
rounding matrix is known to not only influence cell shape
but also to control cell response and gene expression [17].
Indeed this has been shown to be a mechanism that is
important in the regulation of osteoblast differentiation
[26,27] and response to BMPs [28-30]. To demonstrate
that Tol-ST surfaces could be used to probe this phenom-
enon, different densities of Tol-OPN-ST were character-
ised for their ability to support BMP dependent
signalling. A SMAD-responsive reporter construct
showed significantly greater activation in response to
srBMP-2 when cells were cultured on Tol-OPN-ST at 2.7
× 109-3.3 × 1010 molecule/mm2 compared to 2.3 × 108
molecules/mm2 and lower. It is particularly noteworthy
that the apparent threshold for formation of abundant
cell adhesion plaques (1.6 × 1010  molecules/mm2) is
higher than that for BMP receptor activation and signal
transduction (2.7 × 1010 molecules/mm2). This suggests
that the mechanisms regulating BMP receptor signalling
may well be independent of cytoskeletal organisation
controlled by integrin adhesion to Tol-OPN-ST. On other
substrates, αvβ integrins [29] and Focal Adhesion Kinase
(FAK) [31] have both been implicated in the osteoblastic
response to BMP. Our results support general matrix-
dependent BMP signalling in terms of FAK activity since
weakly adherent cells demonstrated poor BMP responses
whilst well adhered and spread cells exhibited elevated
BMP effects. Nevertheless this does not exclude a role for
integrin subunit specific responses with BMPRI and
BMPRII directly associating with αv and β1 integrins [29],
on appropriate external ECM ligands, to give altered
responses.
Tol-BMP-ST maintained BMP-like activity and like
srBMP-2 was able to activate the Smad signalling cascade.
This is in agreement with the work of Saito et al (2003)
who showed that a synthetic BMP2 knuckle peptide was
able to induce alkaline phosphatase activity in C2C12
cells but less effectively than srBMP2 [16]. Previous work
[32,33] has shown that immobilised BMP2 more effec-
tively activates differentiation of osteoblasts than soluble
BMP2. Tol-BMP-ST was immobilised on gold surfaces,
back-filled with TEG-thiol and then compared with solu-
ble recombinant BMP-2 for the ability to regulate osteo-
blast activity and bone formation. Immobilized Tol-BMP-
ST showed activation of SMAD responsive elements
driving luciferase expression in transfected cells. Interest-
ingly the level of activation of signalling by the immobil-
ised ligand was comparable to soluble recombinant
BMP2, demonstrating its enhanced activity compared to
soluble Tol-BMP-ST. The activity of this BMP2 knuckle
peptide is postulated to be mediated through its interac-
tion with BMP receptors I and II (BMPRI and BMPRII)
[16]. Activation of preformed or induced BMPR com-
plexes by soluble BMP results in initiation of intracellular
signalling cascades that include the Smad pathway. In
addition, BMPR complexes are believed to be internalised
by the cell in processes which both alter the signalling
dynamic and lead to loss of or attenuation of activation
[34-38]. It is therefore likely that Tol-BMP-ST surfaces
facilitate prolonged activation of BMP signalling since the
receptor complex would be retained at the cell surface by
the immobilised ligand and prevented from trafficking
into the cell for example via lipid rafts. This is supported
by the work of others which shows that immobilised
Figure 6 Micro-patterned Tol-BMP-ST supported spatially re-
stricted differentiation of calvarial-derived cells. Tol-BMP-St was 
patterned onto gold surfaces using a soft lithography approach to cre-
ate 150 μm diameter circles of scaffold protein. Cells were cultured on 
these surfaces for 14 days. (a) Cell distribution was assessed by DAPI 
staining for nuclear DNA and (b) cell differentiation was investigated 
by alkaline phosphatase staining (blue).Mitchell et al. BMC Biology 2010, 8:57
http://www.biomedcentral.com/1741-7007/8/57
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recombinant BMP2 causes prolonged activation of osteo-
genic gene expression and enhanced osteoblast differenti-
ation [39,40].
When cells were plated on Tol-BMP-ST under routine
culture conditions, cell differentiation occurred during
long term experiments with evidence of the formation of
abundant bone-like nodules. In contrast, few mineralised
matrix deposits were observed on Tol-OPN-ST and bare
gold. Immobilised BMP has previously been shown to
support osteogenic differentiation in vitro [32,40,41]
using MC3T3-E1 cells and BMP2 that was immobilized
by a heat treatment process. Data presented here use pri-
mary cells that are a heterogeneous population that retain
the potential to differentiate to several different lineages
but this is the first time that a tethered ligand alone and in
the complete absence of other agents like dexamethasone
not only induces ostegenic differentiation but also exten-
sive deposition of a mineralized bone-like matrix. This
illustrates the enhanced and sustained signalling pro-
vided by the Tol-BMP-ST surface reinforced cell regula-
tor cues that drive the temporal control of cell phenotype.
Furthermore Tol-BMP-ST on gold reproduces the asym-
metric directional control of bone formation observed in
vivo, a process that is believed to be guided by immobil-
ised ligands. The formation of bone-like nodules in vitro
requires extensive cell motility with the formation of
three-dimensional cell aggregates and therefore the
immobilised signal derived from Tol-BMP-ST is likely to
be relayed to cells away from the surface by cell:cell inter-
actions and paracrine signalling.
Spatial control of osteoblast differentiation was demon-
strated by using microcontact printing of Tol-BMP-ST.
This approach has been used widely in cell culture studies
[42] with predominantly ECM motifs but this is the first
time that cell differentiation motifs have been presented
in this way. This showed that it is immobilised Tol-BMP-
SP and not ligand lost from the surface that is directing
cell behaviour. Work using an inkjet approach has
recently reported similar findings with recombinant
BMP2 spotted on a fibrin layer [43] illustrating the poten-
tial for patterns of immobilised biological ligands to con-
trol cell behaviour in a way that is spatially restricted.
Conclusions
Understanding the molecular mechanisms of cell interac-
tions and their regulation by surrounding matrix cues has
important implications for biotechnology (production of
cells and cell products) and medicine (tissue engineering,
prosthetic implants, cancer and developmental biology).
For example, it provides the basis for fabrication of scaf-
folds bearing biomimetics and/or therapeutics to facili-
tate tight control of cell phenotype in a target tissue. The
technology described here, which immobilises recombi-
nant proteins, is a highly controlled, adaptable and repro-
ducible approach that allows the creation and screening
of surfaces displaying bioactive cell interaction motifs.
We have shown that this approach can provide an insight
into the role of immobilised ligands in regulating cell
behaviour, the interplay with soluble factors and the
influence of spatially controlled signalling. Furthermore,
this approach presents a durable surface that allows both
short (hours or days) and long term (weeks) effects on cell
activity to be assessed. Therefore this technology will
considerably enhance current approaches that utilise cell-
scaffold technology and also undoubtedly provide signifi-
cant new data and therapeutic applications.
Methods
Production of recombinant proteins in E. Coli and their 
immobilization on gold surfaces
TolAIII-Switch tag fusion protein expression constructs
(Tol-motif- S T )  w e r e  b a s e d  o n  t h e  p T o l - T  v e c t o r ,
expressed in E. coli BL-21 cells and purified as detailed
previously (Anderluh et al 2003). The motifs derived
from osteopontin (SVVYGLRGSGSGS) and BMP-2 (KIP-
KASSVPTELSAISTLYL) were engineered into the
expression construct using a synthetic oligonuleotide
approach. The potential for recombinant proteins to
interact with a gold surface was evaluated using Surface
Plasmon Resonance (SPR). The gold surface was cleaned
with Piranha solution for 30 minutes, rinsed with H2O,
1% (w/v) sodium dodecyl sulphate (SDS) and finally
extensively with H2O before drying with air and immedi-
ate docking into the Biacore X system. A buffer of 200
mM NaCl, 0.5 mM EDTA, and 20 mM Tris pH 8.0 was
used for all solutions and also as the running buffer. The
solutions used for thiol binding steps were supplemented
with 0.1 mM TCEP (Tris(2-carboxyethyl)phosphine
hydrochloride) for one hour before use. SPR analysis was
used to calculate protein surface density (molecules/
mm2) based on the observation that an increase of 1 rU
equates to 1 pg/mm2. Molecules/mm2  could then be
found from rU increase × A/(Mr protein × 1012), where A
= Avogadro's number. In all experiments, except where
indicated, the Tol-motif-ST proteins were used to prepare
surfaces with the densities outlined in Table 1. Surfaces
for cell culture were prepared as above on gold-coated
coverslips but were finally then immersed in 0.5 mM
TEG-thiol (11-mercapto-1-triethyleneglycolundecane,
HSC11-EG3) (ProChimia Surfaces, Sopot, Poland) for
four hours to complete the formation of a surface mono-
layer.
Microcontact printing on cleaned gold coverslips
CAD software was used to produce a five-inch mask
design outlining individual 64 mm2 patterned dies. The
mask was manufactured by Delta Mask Bv (Enschede,
Netherlands) to a tolerance of 0.35 μm. A patterned sili-Mitchell et al. BMC Biology 2010, 8:57
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con wafer was fabricated from the mask using standard
photolithographic techniques to create a photoresist
master. The mold was silanized by leaving overnight in
chlorotrimethylsilane vapour. Polydimethylsiloxane (Dow
Corning, MIDLAND, MI, USA) was prepared as directed
by the manufacturer and poured to a depth of 5 mm over
the photoresist master, the chamber was degassed and
left overnight to cure. Final cure of the PDMS was
achieved by placing in an oven at 60°C for one hour.
Stamps were cut from the PDMS layer with a scalpel and
gently peeled away from the photoresist. In the experi-
ments described here a stamp was used that created cir-
cles 150 μm in diameter within a 300 μm square array.
The polydimethylsiloxane (PDMS) stamps were rinsed in
water to remove any debris, and then immersed in etha-
nol and dried in a stream of compressed air, before being
inked using recombinant Tol-BMP-ST (5 mM) and then
dried in a stream of compressed air. The stamps were
then placed on the surface of the Piranha-treated gold,
left for 15 seconds and then the gold surface allowed to
dry for 10 minutes. The gold surfaces were then
immersed in 0.5 mM TEG-thiol (11-mercapto-1-triethyl-
eneglycolundecane, HSC11-EG3) (ProChimia Surfaces,
Sopot, Poland) for four hours.
Cell isolation and culture
Culture media and supplements were obtained from
Invitrogen (Paisley, UK) unless otherwise stated. Primary
rat osteoblasts were isolated from three-day-old rat
(Sprague Dawley) calvariae (Charles River UK Ltd, Mar-
gate, Kent, UK) based on methods previously described
[18]. Cells were grown in Dulbecco's modified Eagle's
medium (DMEM) supplemented with 10% fetal calf
serum (FCS), 100 μg/ml streptomycin and 100 U/ml pen-
icillin (all Invitrogen Ltd, Paisley, UK) at 37°C in a humid-
ified atmosphere with 5% CO2. Cells were used up to
passage 2 and subcultured using routine tissue culture
approaches.
Immunofluorescence
Cells at 70 to 80% confluence were trypsinised and resus-
pended in complete media. Cells were then seeded into
six well plates containing gold-coated coverslips display-
ing the appropriate SAMs and incubated for 24 hours at
37°C in a humidified atmosphere with 5% CO2. Cells were
then rinsed with PBS (Becton Dickinson UK Ltd, Oxford,
UK) and fixed with 4% (w/v) paraformaldehyde in PBS for
15 to 20 minutes. Cells were permeabilised by incubation
for five minutes in 0.1% Triton X-100 (v/v) in PBS and
incubated for one hour at room temperature in 1:200
dilution of monoclonal mouse anti vinculin antibody
(V9131 - Sigma-Aldrich Company Ltd, Gillingham, Kent,
UK)). Samples were rinsed with PBS and incubated with a
FITC-goat anti-mouse antibody (Zymed Laboratories
Invitrogen Ltd, Paisley, UK). Following a wash step, cells
were overlayered with VectaShield containing DAPI
(Vector Laboratories Ltd, Peterborough, UK) and
mounted for microscopy. The samples were then visual-
ized on a Leica fluorescence microscope and images cap-
tured using Spot cooled CCD camera and software with
digital images being analysed using ImageJ (Freeware). In
analysis of cell morphology, circularity was defined as
4π(area/perimeter2).
BMP responsiveness of cells
A luciferase reporter construct that was under the tran-
scriptional control of 6× SMAD binding elements was
used to demonstrate BMP induced intracellular signalling
cascade [44]. Cells were seeded overnight to 50 to 60%
confluency and then transfected with the reporter con-
struct using Fugene (Roche, Burgess Hill, UK). Cells were
then either plated onto the SAMs and luciferase activity
assessed at the time points indicated or transfected cells
were treated with soluble recombinant protein and
response investigated. Luciferase activity was measured
using the Bright-Glo™ Luciferase Assay System (Promega
UK Ltd, Southampton, UK) and an automated microlu-
minometer (MicroLumat Plus, Berthold Technologies
(UK) Ltd, Harpenden, UK).
Mineralised matrix and alkaline phosphatase staining
Alizarin red detects the presence of calcific deposition
within the matrix by binding calcium ions to form a com-
plex that is intensely red. Cells were washed in PBS and
incubated in 1% (w/v) Alizarin red (pH 4.0) solution for
20 minutes in the dark before a final wash in distilled
water. Cells on surfaces were then mounted onto glass
slides and mounted in Vectashield with DAPI (Vector
Laboratories Ltd, Peterborough, UK). To visualize alka-
line phosphatase activity cell monolayers were fixed for
10 minutes in 4% (w/v) paraformaldehyde in PBS and
then incubated in napthol AS-X phosphate and Fast Blue
RR (pH8.4).
Statistical Analysis
In all experiments data was analysed by ANOV A using
either a Fisher or Tukey post test. Statistical significance
was considered at *P < 0.05 and **P < 0.01. Experiments
are presented as representative or at least three indepen-
dent experiments: for analysis of cell number n = 8; for
investigation of area, circularity and vinculin staining n =
20; for luciferase assays n = 6.
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